152 related articles for article (PubMed ID: 6669479)
1. Immunological role of vitamin A and its related substances in prevention of cancer.
Tomita Y
Nutr Cancer; 1983; 5(3-4):187-94. PubMed ID: 6669479
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of tumor immunity against syngeneic tumors in mice by beta-carotene.
Tomita Y; Himeno K; Nomoto K; Endo H; Hirohata T
J Natl Cancer Inst; 1987 Apr; 78(4):679-81. PubMed ID: 3470543
[TBL] [Abstract][Full Text] [Related]
3. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
Tsujino M
Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of astaxanthin and its mode of action.
Jyonouchi H; Sun S; Iijima K; Gross MD
Nutr Cancer; 2000; 36(1):59-65. PubMed ID: 10798217
[TBL] [Abstract][Full Text] [Related]
5. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism].
Gomi K; Morimoto M; Nomoto K
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1262-8. PubMed ID: 7184454
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
Gomi K; Morimoto M; Nomoto K
Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
[TBL] [Abstract][Full Text] [Related]
7. Combined treatments with vitamin A and 5-fluorouracil and the growth of allotransplantable and syngeneic tumors in mice.
Tomita Y; Himeno K; Nomoto K; Endo H; Hirohata T
J Natl Cancer Inst; 1982 May; 68(5):823-7. PubMed ID: 6951091
[TBL] [Abstract][Full Text] [Related]
8. Induction of antitumor immunity by tumor cells treated with abrin.
Shionoya H; Arai H; Koyanagi N; Ohtake S; Kobayashi H; Kodama T; Kato H; Tung TC; Lin JY
Cancer Res; 1982 Jul; 42(7):2872-6. PubMed ID: 7083176
[TBL] [Abstract][Full Text] [Related]
9. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
Milas L; Hunter N; Mason K; Withers HR
Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
[No Abstract] [Full Text] [Related]
10. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
Livingston PO; Jones M; Deleo AB; Oettgen HF; Old LJ
J Immunol; 1985 Aug; 135(2):1505-9. PubMed ID: 4008930
[TBL] [Abstract][Full Text] [Related]
11. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
[No Abstract] [Full Text] [Related]
12. Marked reduction of subcutaneous tumor growth by intraperitoneal administration of recombinant human interleukin 2 with a cell accumulator, proteose-peptone, in mice.
Tanida S; Uchida H; Taniguchi K; Nomoto K
Cancer Res; 1989 Jan; 49(2):284-8. PubMed ID: 2783379
[TBL] [Abstract][Full Text] [Related]
13. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
[TBL] [Abstract][Full Text] [Related]
14. Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors.
Kataoka T; Matsuura N; Oh-hashi F; Suhara Y
Cancer Res; 1985 Aug; 45(8):3548-53. PubMed ID: 2410097
[TBL] [Abstract][Full Text] [Related]
15. Effects of Corynebacterium granulosum on weight and histology of lymphoid organs, response to mitogens, skin allografts, and a syngeneic fibrosarcoma in mice.
Milas L; Basic I; Kogelnik HD; Withers HR
Cancer Res; 1975 Sep; 35(9):2365-74. PubMed ID: 807323
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of recombinant human interferon alpha A/D on Meth-A sarcoma in mice.
Yoshie O; Aso H; Nanjo M; Tamura K; Ebina T; Ishida N
Jpn J Cancer Res; 1986 Apr; 77(4):413-8. PubMed ID: 3084432
[TBL] [Abstract][Full Text] [Related]
17. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system].
Ebina T; Shishido K; Murata K
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1345-50. PubMed ID: 2369138
[TBL] [Abstract][Full Text] [Related]
18. Comparison of approaches for augmenting the serologic response to the individually specific methylcholanthrene-induced sarcoma-Meth A: pretreatment with cyclophosphamide is most effective.
Livingston PO; DeLeo AB; Jones M; Oettgen HF
J Immunol; 1983 Nov; 131(5):2601-5. PubMed ID: 6631013
[TBL] [Abstract][Full Text] [Related]
19. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
[TBL] [Abstract][Full Text] [Related]
20. Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.
Henderson DC; Parker D; Turk JL
Immunology; 1980 Jan; 39(1):1-9. PubMed ID: 7380461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]